Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.

Mingyue CaiWensou HuangWei LiangYongjian GuoLicong LiangLiteng LinLulu XieJingwen ZhouYe ChenBihui CaoJingqiang WuKang-Shun Zhu

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

Len-Sin-TACE showed promising antitumour activities with a manageable safety profile in patients with advanced stage HCC. The preliminary results need to be further evaluated with phase III randomized trials.

Keyphrases

phase ii study
phase iii
open label
placebo controlled
clinical trial
phase ii
radiofrequency ablation
locally advanced
double blind
study protocol
rectal cancer
squamous cell carcinoma
liver metastases